MedDataX Logo

Research on Suicidal Ideation of University Students in Harbin City and Cognitive Behavior Therapy

NCT ID: NCT00575575

Last Updated: 2009-02-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

355 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-06-30

Study Completion Date

2009-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purposes of this research are:

* to understand the status of suicidal ideation, suicidal behavior, and depression in Harbin University students; and
* to analyse the infect factors of suicidal ideation and suicidal behavior.

With cognitive behavior interventions on students with suicidal ideation, suicidal behavior, and middle or high degree of depression, the researchers can provide a scientific and effective intervention to the students.

Cognitive therapy for the prevention of suicide attempts: a randomized controlled trial.

Brown GK, Ten Have T, Henriques GR, Xie SX, Hollander JE, Beck AT. Department of Psychiatry, University of Pennsylvania, Philadelphia 19104, USA. [email protected] JAMA. 2005 Aug 3;294(5):563-70.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

By using suicidal ideation scale, to assess the status of suicidal ideation and suicidal attempt in 6000 university students in Harbin city. About 300 students with suicidal ideation and depression disorder randomized into two groups (control and intervention groups) accept the cognitive behavior intervention. We will assess the depression after intervention.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Suicide

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Suicidal ideation cognitive behavior therapy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A,2

Group Type EXPERIMENTAL

cognitive behavior therapy

Intervention Type BEHAVIORAL

cognitive behavior therapy once a week

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

cognitive behavior therapy

cognitive behavior therapy once a week

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Suicidal ideation or the scores of Beck Depression Inventory ≧14

Exclusion Criteria

* have no Suicidal ideation and the scores of Beck Depression Inventory \<14
Minimum Eligible Age

17 Years

Maximum Eligible Age

35 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Harbin Medical University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Harbin Medical University

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yanjie Yang, doctor

Role: STUDY_DIRECTOR

Harbin Medical University

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

19678181

Identifier Type: -

Identifier Source: secondary_id

196781

Identifier Type: -

Identifier Source: org_study_id